Xenon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Go back to Xenon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update| (NASDAQ: XENE) | Delayed: 59.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.55 | 52 Week High | $9.75 | |||
| Open | $59.55 | 52 Week Low | $5.65 | |||
| Day High | $59.55 | P/E | N/A | |||
| Day Low | $59.55 | EPS | $0.00 | |||
| Volume | 620 | |||||
